Moreover, EZH2 can induce epithelial mesenchymal transition (EMT) and increase the metastatic potential of prostate cancer cells by downregulating DAB2IP, a tumour suppressive Ras GTPase-activating protein (RasGAP)30. The gene discussed is EZH2; the disease is Familial prostate cancer.